How this list was created

The 5 recommendations of SIFACT were discussed and identified through a dedicated website in which the proposals of recommendation were uploaded and comments by participants were collected. The development of these recommendations has involved a group of 20 pharmacists, who proposed more than 25 topics that were thought to be potentially suitable for this initiative.Ten of these recommendations were identified within a project of disinvestment completed in November 2015 (Messori A, Trippoli S, Fadda V, Maratea D. Producing evidence in support of disinvestment: the experience of the Tuscany region in Italy. Eur J Intern Med. 2015 Nov 9. pii: S0953-6205(15)00350-7. doi: 10.1016/j.ejim.2015.10.021, url http://www.osservatorioinnovazione.net/papers/ejim2015.pdf ), but this material was thought to be too oriented towards economic purposes so that these topics were excluded from the final 5 recommendations.
Among the remaining 15 recommendations, 5 were finally selected and represented those submitted by SIFACT to Slow Medicine. Overall, a total of 8 pharmacists contributed to write these 5 recommendations. The evidence on which these 5 recommendations were based was the following: at least one meta-analysis of randomized trials (recommendations 1, 4 and 5), at least two randomised trials (recommendation 3), one prospective cohort study (recommendation 2).
Contributors: Riccardo Bertin, Maria Font, Daniele Mengato, Andrea Messori, Rossella Moscogiuri, Cristina Puggioli, Roberta Rampazzo, Sabrina Trippoli.